Zobrazeno 1 - 10
of 112
pro vyhledávání: '"diagnosis [Parkinson Disease]"'
Autor:
Daniela Renftle, Sara Becker, Kathrin Brockmann, Thomas Gasser, Katja Michaelis, Susanne Solbrig, Patricia Sulzer, Andreas Johnen, Inga Liepelt-Scarfone
Publikováno v:
Dementia and geriatric cognitive disorders 51(3), 271-278 (2022). doi:10.1159/000525618
Introduction: Ideomotor apraxia, a disorder of skilled movements affecting limbs and/or face, can be seen in patients with Parkinson’s disease (PD), yet tests of apraxia in PD are rare. The aim of this project was to evaluate the psychometric prope
Autor:
Matthias Schmitz, Niccolò Candelise, Sezgi Canaslan, Hermann C. Altmeppen, Jakob Matschke, Markus Glatzel, Neelam Younas, Saima Zafar, Peter Hermann, Inga Zerr
Publikováno v:
Translational neurodegeneration 12(1), 12 (2023). doi:10.1186/s40035-023-00342-4
α-Synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy, are a class of neurodegenerative diseases exhibiting intracellular inclusions of misfolded α-synuclein (αSyn), referred to as Lew
Autor:
Siderowf, Andrew, Concha-Marambio, Luis, Galasko, Douglas, Kieburtz, Karl, Merchant, Kalpana, Mollenhauer, Brit, Poston, Kathleen L, Seibyl, John, Simuni, Tanya, Tanner, Caroline M, Weintraub, Daniel, Videnovic, Aleksandar, Lafontant, David-Erick, Choi, Seung Ho, Kurth, Ryan, Caspell-Garcia, Chelsea, Coffey, Christopher S, Frasier, Mark, Oliveira, Luis M A, Hutten, Samantha J, Sherer, Todd, Marek, Kenneth, Soto, Claudio, Farris, Carly M, Initiative, Parkinson's Progression Markers, Ma, Yihua, Urenia, Paula A, Nguyen, Hieu, Alcalay, Roy N, Chahine, Lana M, Foroud, Tatiana
Publikováno v:
The lancet / Neurology 22(5), 407-417 (2023). doi:10.1016/S1474-4422(23)00109-6
Emerging evidence shows that α-synuclein seed amplification assays (SAAs) have the potential to differentiate people with Parkinson's disease from healthy controls. We used the well characterised, multicentre Parkinson's Progression Markers Initiati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c46b0707649acafed2ebfedcd448b7
Autor:
Nils Schröter, Thilo van Eimeren, Joseph Classen, Johannes Levin, Christoph Redecker, Martin Wolz, Lars Tönges
Publikováno v:
Journal of neural transmission 130(6), 839-846 (2023). doi:10.1007/s00702-023-02634-5
The clinical presentation of Parkinson’s disease and atypical Parkinsonian syndromes is often heterogeneous. Additional diagnostic procedures including brain imaging and biomarker analyses can help to appreciate the various syndromes, but a precise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b9f51123944da52e15d5b84c2d26bf
Autor:
Dorothee Kübler, Melanie Astalosch, Verena Gaus, Patricia Krause, Ana Luísa de Almeida Marcelino, Gerd-Helge Schneider, Andrea Kühn
Publikováno v:
Neurological sciences 44(5), 1625-1631 (2023). doi:10.1007/s10072-023-06598-y
Introduction and goal The investigation of gender differences in treatment response is crucial for effective personalized therapies. With only 30%, women are underrepresented in trials for deep brain stimulation (DBS) in Parkinson’s disease (PD). I
Autor:
Inga Zerr, Fabian Maass, Paul Lingor, Bernhard Michalke, Sezgi Canaslan, Mathias Bähr, Matthias Schmitz, Desiree Willkommen
Publikováno v:
Movement disorders 36(12), 2967-2969 (2021). doi:10.1002/mds.28790
Longitudinal PD CSF samples were subjected to ICP-MS and the total amount of iron and other bioelements was quantified. Additionally, ferritin and protein biomarkers of neurodegeneration were measured. Over time, mean iron levels significantly increa
Autor:
Thilo van Eimeren, Joseph Claßen, Christoph Redecker, Jiri Koschel, Rüdiger Hilker-Roggendorf, Alexander Drzezga, Philipp T. Meyer, Carsten Eggers, Hendrik Theis, Carsten Buhmann, Jochen Klucken
Publikováno v:
Fortschritte der Neurologie, Psychiatrie 88(9), 609-619 (2020). doi:10.1055/a-1207-0515
ZusammenfassungDie vorliegende Arbeit gibt einen Überblick über die verschiedenen nuklearmedizinischen Verfahren in der Diagnostik bei neurodegenerativen Parkinson-Syndromen sowie ihre Evidenzlage und soll praxistaugliche Entscheidungshilfen in der
Autor:
Michels, Jennifer, Van Der Wurp, Hendrik, Kalbe, Elke, Rehberg, Sarah, Storch, Alexander, Linse, Katharina, Schneider, Christine, Gräber, Susanne, Berg, Daniela, Dams, Judith, Balzer-Geldsetzer, Monika, Hilker-Roggendorf, Rüdiger, Oberschmidt, Carola, Baudrexel, Simon, Witt, Karsten, Schmidt, Nele, Deuschl, Günther, Mollenhauer, Brit, Trenkwalder, Claudia, Liepelt-Scarfone, Inga, Spottke, Annika, Roeske, Sandra, Wüllner, Ullrich, Wittchen, Hans-Ulrich, Riedel, Oliver, Kassubek, Jan, Dodel, Richard, Schulz, Jörg Bernhard, Costa, Ana Sofia, Reetz, Kathrin, van der Wurp, Hendrick, Bernhard Schulz, Jörg
Publikováno v:
Journal of Parkinson's Disease 12(3), 905-916 (2022). doi:10.3233/JPD-212787
Background: Parkinson’s disease (PD) is associated with various non-motor symptoms, including cognitive deterioration. Objective: Here, we used data from the DEMPARK/LANDSCAPE cohort to describe the association between progression of cognitive prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1ab4bc949c99c610c3515e2ffb58c5
Autor:
Oliver Riedel, Elke Kalbe, Raymond Pomponio, Jörg B. Schulz, Rüdiger Hilker-Roggendorf, Daniel Charissé, Alexander Storch, Nele Schmidt, Karsten Witt, Jan Kassubek, Martin Gorges, Simon Baudrexel, Inga Liepelt-Scarfone, Richard Dodel, Christine Schneider, Daniela Berg, Guray Erus, Kathrin Reetz
Publikováno v:
Neurobiology of aging 109, 31-42 (2022). doi:10.1016/j.neurobiolaging.2021.08.020
Recently, it was shown that patients with Parkinson's disease (PD) who exhibit an "Alzheimer's disease (AD)-like" pattern of brain atrophy are at greater risk for future cognitive decline. This study aimed to investigate whether this association is d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::662a3a6d8fd956d1c4728b30164208c8
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/91122
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/91122
Autor:
Anette Schrag, Jens Bohlken, Lotte Dammertz, Stefan Teipel, Wiebke Hermann, Manas K. Akmatov, Jörg Bätzing, Jakob Holstiege
Publikováno v:
JAMA neurology 80(2), 161–171 (2023). doi:10.1001/jamaneurol.2022.3902
ImportanceThe prodromal phase of Parkinson disease (PD) may last for more than 10 years. Recognition of the spectrum and occurrence of risk factors, comorbidities, and prodromal features of PD can increase understanding of the causes and development